Abstract
Hospital-acquired infections increase cost, morbidity, and mortality for patients across the United States and the world. Principal among these infections are central line-associated bloodstream infection, catheter-associated urinary tract infection, Clostridioides difficile, and methicillin-resistant Staphylococcus aureus colonization and infections. This article provides succinct summaries of the background, epidemiology, diagnosis, and treatment of these conditions. In addition, novel prevention strategies, including those related to recent national interventions, are reviewed.
Keywords:
Bloodstream infection; Catheter-associated urinary tract infection (CAUTI); Central line–associated bloodstream infection (CLABSI); Clostridioides difficile colitis; Hospital-acquired infection; Methicillin-resistant Staphylococcus aureus; Urinary tract infection.
Published by Elsevier Inc.
MeSH terms
-
Bacteremia / drug therapy
-
Bacteremia / microbiology
-
Bacteremia / prevention & control*
-
Bacteremia / therapy
-
Catheter-Related Infections / diagnosis
-
Catheter-Related Infections / epidemiology*
-
Catheter-Related Infections / prevention & control
-
Catheter-Related Infections / therapy
-
Catheters, Indwelling / adverse effects
-
Central Venous Catheters / adverse effects
-
Clostridium Infections / diagnosis
-
Clostridium Infections / epidemiology*
-
Clostridium Infections / prevention & control
-
Clostridium Infections / therapy
-
Cross Infection / microbiology
-
Cross Infection / prevention & control
-
Humans
-
Incidence
-
Methicillin-Resistant Staphylococcus aureus / isolation & purification
-
Staphylococcal Infections / diagnosis
-
Staphylococcal Infections / epidemiology*
-
Staphylococcal Infections / prevention & control
-
Staphylococcal Infections / therapy
-
United States / epidemiology
-
Urinary Tract Infections / diagnosis
-
Urinary Tract Infections / epidemiology*
-
Urinary Tract Infections / prevention & control
-
Urinary Tract Infections / therapy